LY293111 sodium

Drugs of the Future

Volumn 21, Issue 6, 1996, Pages 610-614

  Sawyer, J S ^a  

^a ELI LILLY AND COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 [2 PROPYL 3 [3 [2 ETHYL 4 (4 FLUOROPHENYL) 5 HYDROXYPHENOXY]PROPOXY]PHENOXY]BENZOIC ACID;

AIRWAY OBSTRUCTION; ANTIINFLAMMATORY ACTIVITY; DOSE RESPONSE; DRUG BIOAVAILABILITY; INFLAMMATION; LEUKOCYTE MIGRATION; PNEUMONIA; SHORT SURVEY;

EID: 0029889892     PISSN: 03778282     EISSN: None     Source Type: Journal    
DOI: 10.1358/dof.1996.021.06.360855     Document Type: Short Survey

References (26)

1. 4 receptor antagonists. J Med Chem 1993, 36: 3982-4.
2. 4 receptor antagonist. J Med Chem 1995, 38: 4411-32.
3. 4. Bioorg Med Chem Lett 1993, 3: 1985-90.
4. Schmittling, E.A., Sawyer, J.S. Synthesis of diaryl ethers, diaryl thioethers, and diaryl amines mediated by potassium fluoride-alumina and 18-crown-6. J Org Chem 1993, 58: 3229-30.
5. Samuelsson, B. Leukotrienes: Mediators of immediate hypersensitivity reactions and inflammation. Science 1983, 220: 568-75.
6. 4-induced neutrophil activation by LY223982. J Pharmacol Exp Ther 1992, 263: 1009-14.
7. Henderson, W.R. Jr. Eicosanoids and lung inflammation. Amer Rev Respir Dis 1987, 135: 1176-85.
8. 4 receptor antagonists (LY255283 and SC-41930) on calcium mobilization and integrin expression of activated human neutrophils. Prostagland Leuk Essent Fatty Acids 1991, 46: 265-70.
9. Kragballe, K., Voorhees, J.J. Arachidonic acid in psoriasis. Pathogenic role and pharmacological regulation. Acta Dermato-Venereol 1985, Suppl. 120: 12-7.
10. Stenson, D.W. Role of eicosanoids as mediators of inflammatory bowel disease. J Gastroenterol 1990, 25(Suppl. 172): 13-8.
11. 4 plays a critical role in the progression of collagen-induced arthritis. Proc Natl Acad Sci USA 1995, 92: 517-21.
12. 4, in bronchoalveolar lavage in bronchial asthma and other respiratory diseases. J Allergy Clin Immunol 1989, 84: 19-26.
13. 4 receptor antagonists: Recent clinical developments. Exp Opin Invest Drugs 1996, 5: 73-7.
14. 4 receptor antagonists: The LY255283 series of hydroxyacetophenones. J Med Chem 1992, 35: 1818-28.
15. 4 receptor antagonist. IAIS World Cong Inflamm (Oct 10-15, Vienna) 1993, Abst P75.
16. 4 receptor antagonist. Biochem Pharmacol 1995, 49: 1683-90.
17. 4 Antagonists as Potential Therapeutic Agents (May 19, New York) 1994.
18. 4 receptor antagonist. IAIS World Cong Inflamm (Oct 10-15, Vienna) 1993, Abst P76.
19. 4 aerosol exposure on pulmonary function, cell populations, and mediators in the lungs of rhesus monkeys. Inhal Toxicol 1995, 7: 1141-52.
20. 4 aerosol in rhesus monkeys. J Pharmacol Exp Ther 1996, 277: 341-9.
21. 4 receptor antagonist, in rat and monkey. Pharm Res 1995, 12(9, Suppl.): Abst PPDM 8066.
22. Marder, P., Froelich, L.L., Peterson, B.H., Sawyer, J.S., Crogan, T., Lucas, R.A., Tanner, T., Spaethe, S.M. Discovery and clinical tracking of a potent and selective anti-inflammatory agent using flow cytometric methods. 17th Cong Int Soc Analyt Cytol (Oct 16-21, Lake Placid) 1994.
23. 4 receptor antagonist. Brit J Clin Pharmacol, in press.
24. 4 receptor antagonist LY293111 on the inflammatory response to allergen challenge in atopic asthmatics. Thorax, in press.
25. 4 applications analysed by three-colour flow cytometry. Acta Dermato-Venereol 1995, 75: 437-41.
26. 4 receptor antagonist. Annu Meet Eur Soc Dermatol Res (Sept 23-26, Vienna) 1995.